ORIC Pharmaceuticals, Inc.ORICNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
6.13%
↑ 164% above average
Average (26q)
-9.63%
Historical baseline
Range
High:41.47%
Low:-130.17%
Volatility
-1783.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 6.13% |
| Q2 2025 | -19.40% |
| Q1 2025 | 17.32% |
| Q4 2024 | -3.27% |
| Q3 2024 | -6.39% |
| Q2 2024 | -24.24% |
| Q1 2024 | 7.76% |
| Q4 2023 | -9.57% |
| Q3 2023 | -14.76% |
| Q2 2023 | 2.67% |
| Q1 2023 | -16.09% |
| Q4 2022 | 13.91% |
| Q3 2022 | -24.15% |
| Q2 2022 | 11.02% |
| Q1 2022 | -1.99% |
| Q4 2021 | -23.56% |
| Q3 2021 | 12.35% |
| Q2 2021 | -27.21% |
| Q1 2021 | 41.47% |
| Q4 2020 | -10.47% |
| Q3 2020 | -130.17% |
| Q2 2020 | -21.18% |
| Q1 2020 | -4.65% |
| Q4 2019 | -23.59% |
| Q3 2019 | -11.68% |
| Q2 2019 | -0.14% |
| Q1 2019 | 0.00% |